Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 24
232
Views
3
CrossRef citations to date
0
Altmetric
Short Communications

Anti-inflammatory activity of glycolipids isolated from cyanobacterium Nodularia harveyana

, , , , , , & show all
Pages 6204-6209 | Received 31 May 2020, Accepted 28 Sep 2020, Published online: 28 Oct 2020
 

Abstract

Activity-guided fractionations from the freshwater cyanobacterium Nodularia harveyana led to the isolation of two monogalactosyldiacylglycerols (MGDG), two digalactosyldiacylglycerols (DGDG), two monoglucosyldiacylglycerols (MGlcDG) and 1-(O-hexose)-3,25-hexacosanediol (HG). Structures were elucidated by a combination of 1D and 2D NMR analysis, HRMS and GC-MS. The potential for inhibition against TNF-α and NF-κB production of these seven compounds was tested in THP-1 cells. All compounds showed activity, but compound 7 showed higher inhibitory activity of TNF-α and NF-κB, with IC50 of 4.88 ± 0.13 and 3.64 ± 0.45 μM, respectively.

Graphical Abstract

Supplementary material

Supplementary material relating to this paper is available online. NMR and GC-MS spectra for compounds 17 (Figures 1S–13S) is provided as supporting information.

Disclosure statement

The authors declare no conflict of interest.

Additional information

Funding

This work was supported by the Fundación de la Universidad Autónoma de Madrid.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.